Workflow
汉思能源(00554) - 2018 - 年度财报
HANS ENERGYHANS ENERGY(HK:00554)2019-04-25 08:45

Operations and Facilities - Hans Energy Company Limited operates two main liquid product terminals: Xiao Hu Island Terminal (XHIT) with a total storage capacity of approximately 330,000 cubic meters and Dongzhou International Terminal (DZIT) with a total storage capacity of approximately 260,000 cubic meters[14]. - XHIT has 86 oil and chemical tanks, with 240,000 cubic meters specialized for gasoline, diesel, and similar petroleum products, while DZIT has 94 tanks, with 180,000 cubic meters dedicated to the same products[14]. - The total site area for XHIT is approximately 212,000 square meters, and for DZIT, it is approximately 516,000 square meters[14]. - The company provides integrated facilities for petroleum, liquid chemicals, and gases products, offering value-added services in its own ports and storage tank farms[14]. - The company’s terminals are fully licensed to handle a wide range of dangerous and hazardous goods, ensuring compliance with safety and environmental regulations[18]. Strategic Focus and Growth - Hans Energy aims to expand its logistics services in South China, focusing on enhancing operational efficiency and capacity[14]. - The company is exploring opportunities for market expansion and potential acquisitions to strengthen its position in the industry[14]. - Hans Energy's management emphasizes the importance of technological advancements in enhancing service delivery and operational efficiency[14]. - The company is actively monitoring market trends to adapt its strategies accordingly and ensure long-term growth[14]. - The Company plans to expand its gasoline and diesel retail business, with the first filling station expected to operate in mid-2019, aiming to surpass traditional terminal business in terms of operating income and profitability within two to three years[43]. Financial Performance - The Group's revenue from continuing operations for the year ended December 31, 2018, was approximately HK$141.6 million, representing a year-on-year increase of 27.9%[46]. - Gross profit from continuing operations was approximately HK$33.6 million, with a gross profit margin of 23.7%, reflecting an increase of 225.8% and 14.4 percentage points compared to the previous year[49]. - Loss attributable to equity shareholders from continuing operations was approximately HK$94.8 million, an increase of 46.1% over the prior year, primarily due to a provision for doubtful debts of approximately HK$38.4 million[47]. - EBITDA from continuing operations decreased to HK$16.1 million, down from HK$38.1 million in the previous year[50]. - The revenue from terminal, storage, and transshipment services for liquid products in DZIT increased from HK$110.7 million to HK$141.6 million, representing a 27.9% increase year-on-year[34]. Terminal Operations and Metrics - Terminal throughput for the continuing operation (DZIT) was 3,214,000 metric tons in 2018, representing a 15.7% increase from 2,779,000 metric tons in 2017[24]. - The lease-out rate for oil and chemical products increased to 89.0% in 2018, up by 10.3 percentage points from 78.7% in 2017[24]. - The number of vessels visited at the liquid product terminal decreased by 25.5% to 79 in 2018, while the number of domestic vessels increased by 21.2% to 652[24]. - Transshipment volume for petrochemicals increased by 21.8% to 5,134 metric tons in 2018, compared to 4,214 metric tons in 2017[24]. - The total number of drums filled decreased by 11.9% to 3,389 in 2018, down from 3,845 in 2017[24]. Corporate Governance - The company is actively involved in corporate governance, with independent directors overseeing audit and remuneration committees[67]. - The Board expects that upon completion of the disposal transaction, the liquidity and capital structure of the Group will be substantially improved[52]. - The Company has established formal procedures for the appointment and succession planning of directors[93]. - The Board has a balance of skills and experiences necessary for independent decision-making[91]. - The Company complies with the CG Code, ensuring that corporate governance practices meet regulatory requirements[118]. Human Resources and Employee Welfare - The Group's workforce as of December 31, 2018, consisted of approximately 462 employees, a slight decrease from 476 in 2017[60]. - The company aims to provide reasonable benefits to each eligible employee through insurance policies and employee welfare[62]. - The group pays employee compensation based on industry practices and individual performance, with a total salary and bonus plan budget established annually[62]. - The company is required to purchase social insurance for each eligible employee in China, including retirement, medical, worker's compensation, and unemployment insurance[62]. Risk Management and Internal Control - The Board is responsible for maintaining an adequate risk management and internal control system, which has been considered effective by the Audit Committee[146]. - The Company identifies significant business risks through regular reviews and takes appropriate measures to control and mitigate these risks[4]. - The Group's internal control framework covers all material controls including financial, operational, and compliance controls[4]. - The Board and Audit Committee reviewed the effectiveness of the Group's internal control system and considered it designed to provide reasonable assurance, minimizing risks[4]. Financial Position and Assets - As of December 31, 2018, the Group's total cash and cash equivalents amounted to approximately HK$881 million, a significant increase from HK$41 million in 2017[52]. - The Group's total assets as of December 31, 2018, were approximately HK$1,955 million, up from HK$1,315 million in 2017[52]. - The current ratio decreased to 0.94 as of December 31, 2018, from 1.21 in 2017, primarily due to the recognition of HK$890 million as other payables from a subsidiary disposal[52]. - The gearing ratio increased to 104.3% as of December 31, 2018, compared to 99.4% in 2017, indicating a higher level of debt relative to assets[52]. Board Composition and Leadership - The Board comprises seven directors, including two females and three independent non-executive directors, promoting critical review and control of management processes[111]. - The roles of the Chairman and CEO are segregated, with Mr. David An focusing on strategic planning and business development, while Mr. Yang Dong manages day-to-day operations[117]. - The Company has a diverse board with members holding various key positions in finance and management across different sectors[67]. - The management team includes professionals with over 20 years of experience in the medical and pharmaceutical sectors, enhancing the company's strategic capabilities[75].